Nematollahi, Shima
Pishdad, Gholam Reza
Zakerkish, Mehrnoosh
Namjoyan, Foroogh
Ahmadi Angali, Kambiz
Borazjani, Fatemeh
Clinical trials referenced in this document:
Documents that mention this clinical trial
The effect of berberine and fenugreek seed co-supplementation on inflammatory factor, lipid and glycemic profile in patients with type 2 diabetes mellitus: a double-blind controlled randomized clinical trial
https://doi.org/10.1186/s13098-022-00888-9
Funding for this research was provided by:
Ahvaz Jundishapur University of Medical Sciences (IR.AJUMS.REC.1398.735, IR.AJUMS.REC.1398.735, IR.AJUMS.REC.1398.735, IR.AJUMS.REC.1398.735, IR.AJUMS.REC.1398.735, IR.AJUMS.REC.1398.735)
Article History
Received: 9 April 2022
Accepted: 7 August 2022
First Online: 23 August 2022
Declarations
:
: The Ethical Committee of Jundishapur University of Medical Sciences examined and approved the study, which adhered to the Declaration of Helsinki (IR.AJUMS.REC.1398.735). After outlining the study's goals, each participant in the study provided their written informed consent.
: Not applicable.
: There is no potential conflict of interest.